Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Myrtecaine is a local anesthetic of the ester series used primarily in topical formulations for the relief of muscle strains, tendinitis or ligament sprains, and joint pain. It acts as a surface anesthetic by blocking sodium channels in nerve cells to prevent the initiation and transmission of nerve impulses. This results in localized numbness and pain relief. Myrtecaine is often combined with diethylamine salicylate (as in Algesal or Algésal Suractivé) to enhance analgesic and anti-inflammatory effects by facilitating deeper penetration of the co-administered agent. Additionally, it exhibits muscle relaxant properties[1][2][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on myrtecaine.